Correlation Between Dyadic International and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Larimar Therapeutics, you can compare the effects of market volatilities on Dyadic International and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Larimar Therapeutics.
Diversification Opportunities for Dyadic International and Larimar Therapeutics
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyadic and Larimar is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Larimar Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 1.97 times more return on investment than Larimar Therapeutics. However, Dyadic International is 1.97 times more volatile than Larimar Therapeutics. It trades about 0.26 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 113.00 in Dyadic International on September 16, 2024 and sell it today you would earn a total of 50.00 from holding Dyadic International or generate 44.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dyadic International vs. Larimar Therapeutics
Performance |
Timeline |
Dyadic International |
Larimar Therapeutics |
Dyadic International and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Larimar Therapeutics
The main advantage of trading using opposite Dyadic International and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.Dyadic International vs. Puma Biotechnology | Dyadic International vs. Iovance Biotherapeutics | Dyadic International vs. Inozyme Pharma | Dyadic International vs. Zentalis Pharmaceuticals Llc |
Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |